Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.

Current opinion in pulmonary medicine - 1 Sept 2020

Wongkarnjana Amornpun, Scallan Ciaran, Kolb Martin R J

Abstract excerpt

PURPOSE OF REVIEW: In this review, the authors describe therapeutic strategies for a disease group called progressive fibrosing interstitial lung disease (PF-ILD) and highlight the importance of the definition of progression, prognosis, and treatment response. RECENT FINDINGS: Although it is a relatively new concept, the term PF-ILD has been increasingly applied in clinical research and practice. Three domains...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indoles

Share to Lung Diseases, Interstitial

Share to Protein Kinase Inhibitors

Share to Pulmonary Fibrosis

Share to Pyridones

Share to Vital Capacity

Source

Identifiers

PMID: 32657838
DOI: 10.1097/MCP.0000000000000712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.PMID 32657838Read ↗

Progressive fibrotic interstitial lung disease.Semantic proximity Read ↗

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).Semantic proximity Read ↗

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.Semantic proximity Read ↗

Recent advances in understanding idiopathic pulmonary fibrosisSemantic proximity Read ↗

An IPF-like disease course in disorders other than IPF: how can this be anticipated, recognized, and managed?Semantic proximity Read ↗

The progressive fibrotic phenotype in current clinical practice.Semantic proximity Read ↗

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.Semantic proximity Read ↗

When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases.Semantic proximity Read ↗

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Semantic proximity Read ↗

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

A syndromic framework for progressive pulmonary fibrosis.Semantic proximity Read ↗

Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.